Kessler Jon
Known title: President and CEOCIK: 0001615062
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
HealthEquity Appoints Moody's CFO to Board Amid AI Cash Concerns. HealthEquity has appointed Noémie Heuland, CFO of Moody's, to its board of directors. This governance move comes as market commentary highlights concerns regarding the company's cash position in the context of AI adoption. The stock is currently trading near its 52-week low, with an average analyst target price of $119.33.
Transaction History
| PHR | ▲ Buy | Grant | 19,290 | $185K | 6/24/2026 | View on chart |
| PHR | ▲ Buy | Grant | 20,218 | $0 | 4/6/2026 | View on chart |
| PHR | ▲ Buy | Grant | 4,376 | $0 | 4/6/2026 | View on chart |
| HQY | ▲ Buy | Option Exercise | 17,409 | $719K | 6/6/2025 | View on chart |
| HQY | ▲ Buy | Option Exercise | 23,929 | $1.5M | 6/6/2025 | View on chart |
| HQY | ▲ Buy | Option Exercise | 38,343 | $2.8M | 6/6/2025 | View on chart |
| HQY | ▼ Sell | Open Market | 62,827 | $7.0M | 6/6/2025 | View on chart |
| HQY | ▼ Sell | Open Market | 16,854 | $1.9M | 6/6/2025 | View on chart |
| HQY | ▲ Buy | Option Exercise | 23,930 | $1.5M | 6/6/2025 | View on chart |
| HQY | ▲ Buy | Option Exercise | 12,782 | $941K | 6/6/2025 | View on chart |
| HQY | ▼ Sell | Open Market | 52,450 | $5.9M | 6/6/2025 | View on chart |
| HQY | ▼ Sell | Open Market | 19,082 | $2.1M | 6/6/2025 | View on chart |
| HQY | ▼ Sell | Open Market | 16,547 | $1.9M | 6/6/2025 | View on chart |
| HQY | ▼ Sell | Open Market | 9,628 | $1.1M | 6/6/2025 | View on chart |
| HQY | ▼ Sell | Open Market | 60 | $7K | 6/6/2025 | View on chart |
| HQY | ▼ Sell | Open Market | 39,075 | $4.4M | 6/6/2025 | View on chart |
| HQY | ▼ Sell | Open Market | 15,427 | $1.7M | 6/6/2025 | View on chart |
| HQY | ▲ Buy | Option Exercise | 34,820 | $1.4M | 6/6/2025 | View on chart |
| HQY | ▼ Sell | Tax Withholding | 101,545 | $8.1M | 4/8/2025 | View on chart |
| HQY | ▲ Buy | Grant | 205,055 | $0 | 4/2/2025 | View on chart |
| HQY | ▼ Sell | Open Market | 17,338 | $1.4M | 9/16/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 3,661 | $289K | 9/16/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 7,239 | $567K | 9/16/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 1,511 | $119K | 9/16/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 6,675 | $555K | 6/25/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 2,781 | $231K | 6/25/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 27,124 | $2.2M | 6/24/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 11,270 | $932K | 6/24/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 2,199 | $184K | 6/24/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 5,202 | $435K | 6/24/2024 | View on chart |
| HQY | ▼ Sell | Tax Withholding | 53,295 | $4.3M | 4/1/2024 | View on chart |
| HQY | ▲ Buy | Grant | 103,806 | $0 | 3/27/2024 | View on chart |
| HQY | ▲ Buy | Option Exercise | 60,000 | $840K | 3/22/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 33,765 | $2.7M | 3/22/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 1,027 | $76K | 9/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 1,377 | $103K | 9/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 1,471 | $111K | 9/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 4,699 | $349K | 9/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 6,960 | $521K | 9/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 6,771 | $513K | 9/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 6,279 | $466K | 9/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 9,035 | $684K | 9/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 9,199 | $689K | 9/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 6,276 | $383K | 6/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 5,910 | $360K | 6/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 4,809 | $294K | 6/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 1,316 | $80K | 6/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 938 | $57K | 6/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 7,981 | $486K | 6/27/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 1,621 | $97K | 6/26/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 10,256 | $617K | 6/26/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 7,711 | $464K | 6/26/2023 | View on chart |
| HQY | ▼ Sell | Tax Withholding | 40,309 | $2.3M | 4/3/2023 | View on chart |
| HQY | ▲ Buy | Grant | 86,179 | $0 | 3/29/2023 | View on chart |
| HQY | ▼ Sell | Tax Withholding | 13,667 | $924K | 4/1/2022 | View on chart |
| HQY | ▲ Buy | Grant | 31,788 | $0 | 3/30/2022 | View on chart |
| HQY | ▼ Sell | Other | 4,424 | $0 | 1/12/2022 | View on chart |
| HQY | ▼ Sell | Other | 4,424 | $0 | 1/12/2022 | View on chart |
| HQY | ▲ Buy | Option Exercise | 100,000 | $1.4M | 12/8/2021 | View on chart |
| HQY | ▼ Sell | Gift | 49,026 | $0 | 11/4/2021 | View on chart |
| HQY | ▼ Sell | Gift | 49,026 | $0 | 11/4/2021 | View on chart |
| HQY | ▼ Sell | Gift | 36,860 | $0 | 11/4/2021 | View on chart |
| HQY | ▼ Sell | Gift | 36,860 | $0 | 11/4/2021 | View on chart |
| HQY | ▼ Sell | Other | 53,450 | $0 | 10/26/2021 | View on chart |
| HQY | ▼ Sell | Other | 53,450 | $0 | 10/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Barclays Raises Phreesia Price Target to $11
Barclays has raised its price target for Phreesia to $11 while maintaining an Equal-Weight rating. This update places the firm's outlook within the broader analyst consensus, which currently averages $14.13. The stock remains well below its 52-week high of $24.07, reflecting a significant drop from previous levels.
Barclays Raises Phreesia Price Target to $11. Barclays has raised its price target for Phreesia to $11 while maintaining an Equal-Weight rating. This update places the firm's outlook within the broader analyst consensus, which currently averages $14.13. The stock remains well below its 52-week high of $24.07, reflecting a significant drop from previous levels.